UBS Group’s iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN JJS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-54
| Closed | -$3.52K | – | 10287 |
|
|
2023
Q1 | $3.52K | Buy |
54
+25
| +86% | +$1.56K | ﹤0.01% | 8310 |
|
|
2022
Q4 | $1.73K | Sell |
29
-10
| -26% | -$589 | ﹤0.01% | 9805 |
|
|
2022
Q3 | $2K | Hold |
39
| – | – | ﹤0.01% | 9858 |
|
|
2022
Q2 | $2K | Buy |
+39
| New | +$2.6K | ﹤0.01% | 9720 |
|
|
2022
Q1 | – | Sell |
-645
| Closed | -$40K | – | 11272 |
|
|
2021
Q4 | $40K | Buy |
+645
| New | +$39.9K | ﹤0.01% | 7137 |
|
|
2021
Q3 | – | Sell |
-677
| Closed | -$34K | – | 10382 |
|
|
2021
Q2 | $34K | Sell |
677
-29
| -4% | -$1.4K | ﹤0.01% | 6811 |
|
|
2021
Q1 | $30K | Buy |
706
+50
| +8% | +$2.24K | ﹤0.01% | 7026 |
|
|
2020
Q4 | $28K | Sell |
656
-4
| -0.6% | -$160 | ﹤0.01% | 6706 |
|
|
2020
Q3 | $25K | Buy |
660
+1
| +0.2% | +$38 | ﹤0.01% | 6141 |
|
|
2020
Q2 | $23K | Hold |
659
| – | – | ﹤0.01% | 6478 |
|
|
2020
Q1 | $23K | Sell |
659
-7
| -1% | -$278 | ﹤0.01% | 6415 |
|
|
2019
Q4 | $28K | Hold |
666
| – | – | ﹤0.01% | 6693 |
|
|
2019
Q3 | $25K | Sell |
666
-1
| -0.1% | -$37 | ﹤0.01% | 6614 |
|
|
2019
Q2 | $27K | Hold |
667
| – | – | ﹤0.01% | 6419 |
|
|
2019
Q1 | $27K | Hold |
667
| – | – | ﹤0.01% | 6044 |
|
|
2018
Q4 | $27K | Buy |
+667
| New | +$29.2K | ﹤0.01% | 6571 |
|
UBS Group's JJS Position: Q2 2023 in Review
UBS Group sold out of iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) in Q2 2023, closing a stake of 54 shares — an estimated $3.52K sold.
UBS Group first reported a position in JJS in Q4 2018 and held it in 16 quarters. The position peaked at $40K in Q4 2021. 0 funds tracked by Wall St. Rank hold JJS as of Q2 2023.
- UBS Group reported no remaining iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 54 iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN shares in Q2 2023, an estimated $3.52K.
- UBS Group first reported a position in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN in Q4 2018 and held it in 16 quarters.
- UBS Group's iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN position peaked at $40K in Q4 2021.
- 0 funds tracked by Wall St. Rank held iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.